Results 11 to 20 of about 13,250 (212)
(R)-albuterol decreases immune responses: role of activated T cells
Respiratory Research, 2008 Racemic albuterol is an equimolar mixture of two isomers, (R) and (S). Whether (R) and (S) isomers and the combination of both exert different effects in immune activation is not well defined. We analyzed the effects of (R+S)-albuterol, (R)-albuterol and
Lu Xin +8 more
doaj +2 more sources
Albuterol Improves Alveolar-Capillary Membrane Conductance in Healthy Humans
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2016 Background Beta-2 adrenergic receptors (β 2 ARs) are located throughout the body including airway and alveolar cells. The β 2 ARs regulate lung fluid clearance through a variety of mechanisms including ion transport on alveolar cells and relaxation of ...
Natalie E. Taylor +5 more
doaj +2 more sources
Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis [PDF]
Western Journal of Emergency Medicine, 2018 Introduction: Although bronchiolitis is a common reason for infant hospitalization, significant heterogeneity persists in its management. The American Academy of Pediatrics currently recommends that inhaled albuterol not be used in routine care of ...
Anna Condella +6 more
doaj +2 more sources
Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection [PDF]
International Journal of Pediatrics, 2016 Introduction. Human metapneumovirus (HMPV) is a paramyxovirus from the same subfamily as respiratory syncytial virus (RSV) and causes similar acute lower respiratory tract infection.
Lindsey K. Rasmussen +2 more
doaj +2 more sources
Respiratory Medicine Case Reports, 2015 We describe a case of 13-year-old female with intermittent asthma who developed lactic acidosis and diastolic hypotension after receiving intermittent albuterol nebulizer treatment.
Tehila A. Saadia +2 more
doaj +2 more sources
Two versus four puffs of albuterol: does dose change bronchodilator response?
Journal of Asthma and Allergy, 2019 Anne V McLaughlin,1,2 Anita Bhandari,3 Craig M Schramm1,2 1Department of Pediatric Pulmonary Medicine, Connecticut Children’s Medical Center, Hartford, CT, USA; 2Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT,
McLaughlin AV, Bhandari A, Schramm CM
doaj +1 more source
Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast
World Allergy Organization Journal, 2010 Exercise-induced bronchospasm (EIB) involves airway obstruction with an onset shortly after exercising. It can occur in individuals without a diagnosis of asthma, but is most common in asthmatic patients (and in this scenario may be referred to as ...
Gene Colice, MD, FCCP +1 more
doaj +2 more sources
Journal of Asthma and Allergy, 2017 Edward M Kerwin,1 Thomas J Ferro,2 Rinat Ariely,3 Debra E Irwin,4 Ruchir Parikh3 1Clinical Trials Division, Clinical Research Institute of Southern Oregon, PC, Medford, OR, 2Global Medical Affairs, 3Global Health Economics and Outcome Research, Teva ...
Kerwin EM +4 more
doaj +1 more source
Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells
Clinical Epigenetics, 2023 Background Albuterol is the first-line asthma medication used in diverse populations. Although DNA methylation (DNAm) is an epigenetic mechanism involved in asthma and bronchodilator drug response (BDR), no study has assessed whether albuterol could ...
Javier Perez-Garcia +16 more
doaj +1 more source
Journal of the American College of Emergency Physicians Open, 2021 Objective Albuterol is a β2‐agonist and causes an intracellular shift of potassium from the interstitium. Whole‐body hypokalemia is known to cause skeletal muscle weakness, but whether this occurs as a result of hypokalemia from the intracellular shift ...
Catherine Burger +2 more
doaj +1 more source